Literature DB >> 17386127

TEACH: Tykerb evaluation after chemotherapy.

Beverly Moy1, Paul E Goss.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17386127     DOI： 10.3816/CBC.2007.n.007

Source DB:  PubMed          Journal:  Clin Breast Cancer        ISSN： 1526-8209            Impact factor:   3.225


× No keyword cloud information.
  9 in total

1.  Adjuvant and Neoadjuvant Therapy with Lapatinib in ErbB2-Overexpressing Breast Cancer.

Authors:  Wolfgang Janni; Gunter von Minckwitz; Volker Möbus; Ulrike Nitz
Journal:  Breast Care (Basel)       Date:  2008-04-26       Impact factor: 2.860

Review 2.  Does tumour dormancy offer a therapeutic target?

Authors:  Paul E Goss; Ann F Chambers
Journal:  Nat Rev Cancer       Date:  2010-11-04       Impact factor: 60.716

Review 3.  Tumor metastasis: moving new biological insights into the clinic.

Authors:  Liling Wan; Klaus Pantel; Yibin Kang
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

4.  The role of HER-2 in Breast Cancer.

Authors:  Takashi Ishikawa; Yasushi Ichikawa; Daisuke Shimizu; Takeshi Sasaki; Mikiko Tanabe; Takashi Chishima; Kazuaki Takabe; Itaru Endo
Journal:  J Surg Sci       Date:  2014-12

Review 5.  Trastuzumab as adjuvant systemic therapy for HER2-positive breast cancer.

Authors:  Gabriella Mariani; Angelica Fasolo; Elena De Benedictis; Luca Gianni
Journal:  Nat Clin Pract Oncol       Date:  2008-12-23

6.  Targeting HER2 Positive Breast Cancer with Chemopreventive Agents.

Authors:  Joseph Wahler; Nanjoo Suh
Journal:  Curr Pharmacol Rep       Date:  2015-04-19

7.  Addressing the challenges of a cross-national investigation: lessons from the Pittsburgh-Pisa study of treatment-relevant phenotypes of unipolar depression.

Authors:  Ellen Frank; Giovanni B Cassano; Paola Rucci; Andrea Fagiolini; Luca Maggi; Helena C Kraemer; David J Kupfer; Bruce Pollock; Robert Bies; Vishwajit Nimgaonkar; Paul Pilkonis; M Katherine Shear; Wesley K Thompson; Victoria J Grochocinski; Paolo Scocco; Joan Buttenfield; Rocco Nicola Forgione
Journal:  Clin Trials       Date:  2008       Impact factor: 2.486

8.  The invasive lobular carcinoma as a prototype luminal A breast cancer: a retrospective cohort study.

Authors:  So-Youn Jung; Junsoo Jeong; Seung-Ho Shin; Youngmee Kwon; Eun-A Kim; Kyoung Lan Ko; Kyung Hwan Shin; Keun Seok Lee; In Hae Park; Seeyoun Lee; Seok Won Kim; Han-Sung Kang; Jungsil Ro
Journal:  BMC Cancer       Date:  2010-12-03       Impact factor: 4.430

9.  Putative growth characteristics of micrometastatic breast cancer.

Authors:  Ann F Chambers; Paul E Goss
Journal:  Breast Cancer Res       Date:  2008-11-27       Impact factor: 6.466
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.